ONC250516C370000
- 0.00
- 0.000.00%
BeiGene Newsroom
Results: BeiGene, Ltd. Confounded Analyst Expectations With A Surprise Profit
Market Chatter: WuXi AppTec Chairman Tops China's A-List for Highest Pay in 2024
[Brokerage Focus] CMB International maintains a Buy rating on BEIGENE (06160) for its resilience in the performance of Zebrutinib.
Jinwu Financial News | According to a research report from CCB International, BEIGENE (06160) reported product revenue of 1.11 billion USD for Q1 2025, a year-on-year increase of 48%, but a quarter-on-quarter decrease of 1%. Among these, Zebutini achieved sales revenue of 0.792 billion USD, a year-on-year increase of 62%, and a quarter-on-quarter decrease of 4%. Excluding the positive impact of 30 million USD in Q4 2024 due to client order rhythm and seasonal factors, Zebutini's actual quarter-on-quarter growth in the first quarter this year was about 3%. Given that products in the BTKi category usually experience a slow season in the first quarter, Zebutini's performance is quite resilient. The report indicated that BEIGENE achieved in Q1 2025.
RBC Capital Maintains Outperform on BeiGene, Lowers Price Target to $311
BeiGene Ltd (ONC) Q1 2025 Earnings Call Highlights: Achieving Profitability and Expanding ...
BeiGene Is Maintained at Buy by Guggenheim
BeiGene Price Target Raised to $350.00/Share From $348.00 by Guggenheim
BeiGene Analyst Ratings
Express News | Beigene Ltd : Morgan Stanley Cuts Target Price to $313.00 From $317.00
RBC Trims Price Target on BeiGene to $311 From $312, Keeps Outperform Rating
BeiGene's Strong Market Position and Promising Financial Outlook Drive Buy Rating
TD Cowen Maintains BeiGene(ONC.US) With Buy Rating, Maintains Target Price $334
Research Reports on Gold Mining | HAITONG INT'L: Maintains BEIGENE's "Outperform the Market" rating, Target Price 182.35 Hong Kong dollars.
The research report from Ping An International indicates that in Q1 2025, BEIGENE (6160.HK) achieved a net income of 1.27 million USD (compared to a loss of 0.25 billion USD in Q1 2024), marking the first time it has achieved quarterly operating profit (according to US GAAP). The management maintains the full-year revenue guidance unchanged at 4.9-5.3 billion USD. The firm believes that BEIGENE's overall performance meets expectations. Growth in overseas revenue has helped the company turn profitable. In Q1 2025, the company's product revenue grew by 48.4% year-on-year to 1.11 billion USD, primarily due to increased overseas sales of Zebutinib. There is a bullish outlook on the continued growth of Zebutinib in Q2 2025.
BeiGene Narrows Q1 Loss as Operating Income Jumps 50%
[Brokerage Focus] HAITONG INT'L maintains a "Buy" rating on BEIGENE (06160), stating that its overall performance meets expectations.
Jingwu Financial News | HAITONG INT'L issued a research report, stating that in Q1 2025, BEIGENE (06160) achieved revenue of 1.12 billion USD (up 48.6% year-on-year), of which product revenue was 1.11 billion USD. The Net income attributable to the parent company was 1.27 million USD (a loss of 0.25 billion USD in Q1 2024), marking the first time a single quarter of regular business earnings was achieved (US GAAP standards). Management maintains its annual revenue guidance unchanged at 4.9-5.3 billion USD. The bank believes BEIGENE's performance overall meets expectations. The bank indicated that in Q1 2025, the company's product revenue grew 48.4% year-on-year to 1.11 billion USD, mainly benefiting from the sales of Zebutini.
BeiGene's Earnings Call: Record Growth & Strategic Advances
Hong Kong stock morning report | The Federal Reserve maintained interest rates, and the three major U.S. indexes closed higher. China Concept Stocks broadly declined.
① The Federal Reserve maintained the benchmark interest rate, which met market expectations. ② Federal Reserve Chairman Powell stated that the impact of tariffs is greater than expected and there is no rush to cut interest rates. ③ The three major indexes of the U.S. stock market closed higher, while China Concept Stocks generally fell. ④ The central bank stated that it will make every effort to promote the implementation of a package of financial policies. ⑤ International crude oil and Gold Futures prices fell more than 1%.
BeiGene's Strong Market Position and Growth Potential Affirmed by Buy Rating
BeiGene Targets $4.9B-$5.3B Revenue for 2025 With Strong BRUKINSA and Pipeline Growth
Selected Hong Kong Stock Announcements｜BEIGENE's revenue increased by around 50% in the first quarter, and Geely plans to privatize ZEEKR at a premium.
① BEIGENE's revenue increased by about 50% in the first quarter, what about the profit situation? ② Geely plans to privatize ZEEKR at a premium, what are the highlights?